[go: up one dir, main page]

EP2812694A4 - Tests et procédés de diagnostic du cancer des ovaires - Google Patents

Tests et procédés de diagnostic du cancer des ovaires

Info

Publication number
EP2812694A4
EP2812694A4 EP12867832.3A EP12867832A EP2812694A4 EP 2812694 A4 EP2812694 A4 EP 2812694A4 EP 12867832 A EP12867832 A EP 12867832A EP 2812694 A4 EP2812694 A4 EP 2812694A4
Authority
EP
European Patent Office
Prior art keywords
assays
diagnosis
methods
ovarian cancer
ovarian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12867832.3A
Other languages
German (de)
English (en)
Other versions
EP2812694A2 (fr
Inventor
Kenneth Sisco
Peter Chou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quest Diagnostics Investments LLC
Original Assignee
Quest Diagnostics Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Investments LLC filed Critical Quest Diagnostics Investments LLC
Publication of EP2812694A2 publication Critical patent/EP2812694A2/fr
Publication of EP2812694A4 publication Critical patent/EP2812694A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57449Specifically defined cancers of ovaries
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10Complex mathematical operations
    • G06F17/18Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30Unsupervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5412IL-6
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Databases & Information Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Software Systems (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioethics (AREA)
  • Evolutionary Computation (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Mathematical Optimization (AREA)
  • Computational Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Analysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
EP12867832.3A 2012-02-07 2012-09-26 Tests et procédés de diagnostic du cancer des ovaires Withdrawn EP2812694A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261596107P 2012-02-07 2012-02-07
PCT/US2012/057315 WO2013119279A2 (fr) 2012-02-07 2012-09-26 Tests et procédés de diagnostic du cancer des ovaires

Publications (2)

Publication Number Publication Date
EP2812694A2 EP2812694A2 (fr) 2014-12-17
EP2812694A4 true EP2812694A4 (fr) 2015-07-01

Family

ID=48948147

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12867832.3A Withdrawn EP2812694A4 (fr) 2012-02-07 2012-09-26 Tests et procédés de diagnostic du cancer des ovaires

Country Status (3)

Country Link
US (1) US20150004633A1 (fr)
EP (1) EP2812694A4 (fr)
WO (1) WO2013119279A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015CH03655A (fr) * 2015-07-17 2015-07-31 Wipro Ltd
US11625699B1 (en) 2016-12-27 2023-04-11 Wells Fargo Bank, N.A. Adaptive daily withdrawal limits for smart chip ATM transactions
KR102061800B1 (ko) 2017-07-18 2020-02-11 사회복지법인 삼성생명공익재단 기계 학습을 이용한 난소암의 예후 예측 방법, 장치 및 프로그램

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069963A1 (en) * 2003-08-15 2005-03-31 Lokshin Anna E. Multifactorial assay for cancer detection
US20090004687A1 (en) * 2007-06-29 2009-01-01 Mansfield Brian C Predictive markers for ovarian cancer
US20090075299A1 (en) * 2007-09-14 2009-03-19 Meso Scale Technologies, Llc Diagnostic Methods
US20110033377A1 (en) * 2008-04-23 2011-02-10 Healthlinx Limited Assay to detect a gynecological condition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008123948A1 (fr) * 2007-03-27 2008-10-16 Vermillion, Inc. Biomarqueurs pour cancer des ovaires
WO2009058331A2 (fr) * 2007-10-29 2009-05-07 Vermilllion, Inc. Biomarqueurs permettant la détection du cancer des ovaires à un stade précoce
MX2011009299A (es) * 2009-03-06 2011-10-11 Mochida Pharm Co Ltd Metodo para diagnosticar endometriosis y kits de diagnostico para endometriosis.
CN103582815A (zh) * 2011-02-24 2014-02-12 佛米利昂公司 用于卵巢癌的生物标志物组、诊断方法和测试试剂盒

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069963A1 (en) * 2003-08-15 2005-03-31 Lokshin Anna E. Multifactorial assay for cancer detection
US20090004687A1 (en) * 2007-06-29 2009-01-01 Mansfield Brian C Predictive markers for ovarian cancer
US20090075299A1 (en) * 2007-09-14 2009-03-19 Meso Scale Technologies, Llc Diagnostic Methods
US20110033377A1 (en) * 2008-04-23 2011-02-10 Healthlinx Limited Assay to detect a gynecological condition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY APR 1991, vol. 164, no. 4, April 1991 (1991-04-01), pages 1038 - 1042 ; di, ISSN: 0002-9378 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; April 1991 (1991-04-01), BEREK J S ET AL: "Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer.", XP002739684, Database accession no. NLM2014824 *
T. V. CLENDENEN ET AL: "Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer", CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION, vol. 20, no. 5, 1 May 2011 (2011-05-01), pages 799 - 810, XP055189606, ISSN: 1055-9965, DOI: 10.1158/1055-9965.EPI-10-1180 *

Also Published As

Publication number Publication date
EP2812694A2 (fr) 2014-12-17
US20150004633A1 (en) 2015-01-01
WO2013119279A3 (fr) 2014-05-08
WO2013119279A2 (fr) 2013-08-15

Similar Documents

Publication Publication Date Title
IL264558A (en) Anti–il–23p19 antibodies
ZA201407509B (en) Anti-fcrn antibodies
ZA201407897B (en) Protease-regulated antibodies
ZA201409358B (en) Anti-siglec- 15 antibodies
IL254416B (en) Anti-asic1 antibodies and their uses
SG10201709290XA (en) Anti-H7cr Antibodies
IL233781A0 (en) Antibodies against big-endothelin-1 and their uses
IL230693A0 (en) Use of the i-3859 antibody for the detection and diagnosis of cancer
EP2812694A4 (fr) Tests et procédés de diagnostic du cancer des ovaires
GB201209584D0 (en) Modified antibodies
IL235188A0 (en) Antibodies against c-pdgf
GB201208372D0 (en) Antibodies and uses thereof
GB201206755D0 (en) Serrs based assays for oligonucleotides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140827

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20150603

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/53 20060101AFI20150526BHEP

Ipc: G01N 33/574 20060101ALI20150526BHEP

17Q First examination report despatched

Effective date: 20160825

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20170221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170704